Key Insights: Freenome, a company specializing in early cancer detection, announced that it will lay off 20 percent of its workforce. The decision was shared in a LinkedIn post by the company. The layoffs are part of a strategic realignment to ensure that the company’s…
Key Points from the Article on Follow-Up Measure After Stool-Based CRC Test: Approximately 48% of patients underwent a follow-up colonoscopy…
Key Points: Exact Sciences, a leading provider of cancer screening and diagnostic tests, has launched an initiative with Mayo Clinic…
A multivariable risk prediction model has been developed to prioritize patients at the highest risk for colorectal cancer (CRC) who…
Key Points: There is increasing tension between hospitals and Medicare Advantage (MA) insurers as the program expands and the federal…
Thought Leadership
Key Points: There’s an alarming increase in colorectal cancer among younger Americans,…
Key Points: A leadership conference survey for female gastroenterology healthcare professionals revealed…
Key Points: Direct-to-consumer (DTC) microbiome tests are offered by various companies claiming…
ARTIFICIAL INTELLIGENCE (AI)
Tech & Innovation
Business
Key Insights: Freenome, a company specializing in early cancer detection, announced that…